Suppr超能文献

用小分子中和内源性趋化因子。原理和潜在的治疗应用。

Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications.

机构信息

IREBS, FRE3211, Ecole Supérieure de Biotechnologie de Strasbourg, Boulevard Sébastien Brant, 67412 Illkirch, France.

出版信息

Pharmacol Ther. 2010 Apr;126(1):39-55. doi: 10.1016/j.pharmthera.2009.12.003. Epub 2010 Feb 1.

Abstract

Regulation of cellular responses to external stimuli such as hormones, neurotransmitters, or cytokines is achieved through the control of all steps of the complex cascade starting with synthesis, going through maturation steps, release, distribution, degradation and/or uptake of the signalling molecule interacting with the target protein. One possible way of regulation, referred to as scavenging or neutralization of the ligand, has been increasingly studied, especially for small protein ligands. It shows innovative potential in chemical biology approaches as well as in disease treatment. Neutralization of protein ligands, as for example cytokines or chemokines can lead to the validation of signalling pathways under physiological or pathophysiological conditions, and in certain cases, to the development of therapeutic molecules now used in autoimmune diseases, chronic inflammation and cancer treatment. This review explores the field of ligand neutralization and tries to determine to what extent small chemical molecules could substitute for neutralizing antibodies in therapeutic approaches.

摘要

细胞对外界刺激(如激素、神经递质或细胞因子)的反应的调节是通过控制从合成开始的复杂级联反应的所有步骤来实现的,然后经过成熟步骤、释放、分布、降解和/或与靶蛋白相互作用的信号分子的摄取。一种称为配体清除或中和的可能调节方式已越来越受到研究,特别是对于小蛋白配体。它在化学生物学方法以及疾病治疗方面具有创新性潜力。配体(如细胞因子或趋化因子)的中和可以在生理或病理生理条件下验证信号通路,并且在某些情况下,导致现在用于自身免疫疾病、慢性炎症和癌症治疗的治疗分子的发展。本文综述了配体中和领域,并试图确定小分子在治疗方法中在多大程度上可以替代中和抗体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bd9/7112609/8c1165a52d52/gr1_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验